Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 1, 2007, Pages 109-113

  Rena, Ottavio ^a   Papalia, Esther ^a   Oliaro, Alberto ^b   Ruffini, Enrico ^b   Filosso, PierLuigi ^b   Novero, Domenico ^b   Maggi, Giuliano ^b   Casadio, Caterina ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Radiotherapy; Surgery; Survival; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADIPOSE TISSUE; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; PRIORITY JOURNAL; THYMOMA;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 33845316133     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.10.022     Document Type: Article

References (23)

1. Okumura M., Ohta M., Tateyama H., Nakagawa K., Matsumura A., Maeda H., Tada H., Eimoto T., Matsuda H., and Masaoka A. The World Health Organization histologic classification system reflects the oncologic behaviour of thymoma. A clinical study of 273 patients. Cancer 94 (2002) 624-632
2. Kondo K., Yoshizawa K., Tsuyuguchi M., Kimura S., Sumitomo M., Morita J., Miyoshi T., Sakiyama S., Mukai K., and Monden Y. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77 (2004) 1183-1188
3. Rena O., Papalia E., Maggi G., Oliaro A., Ruffini E., Filosso P.L., Mancuso M., Novero D., and Casadio C. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 50 (2005) 59-66
4. Koga K., Matsuno Y., Noguchi M., Mukai K., Asamura H., Guya T., and Shimosato Y. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44 (1994) 359-367
5. Wilkins E.W., Grillo H.C., Scannell G., Moncure A.C., and Mathisen D.J. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51 (1991) 888-892
6. Nakahara K., Ohno K., Hashimoto J., Maeda H., Miyoshi S., Sakurai M., Monden Y., and Kamashima Y. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 95 (1988) 1041-1047
7. Blumberg D., Port J.L., Weksler B., Delgado R., Rosai J., Bains M.S., Ginsberg R.J., Martini N., McCormack P., Rusch V., and Burt M.E. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60 (1995) 908-914
8. In: Travis W.D., Brambilla E., Mueller-Hermelink H.K., and Harris C.C. (Eds). World Health classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon
9. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymoma with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
10. Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., De Montpreville V., Levi J.F., and Levasseur P. Prognostic factors and long-term results after thymoma resection: a series of 207 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
11. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti M., and Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 51 (1991) 152-156
12. Kohman L.J. Controversies in the management of thymoma. Chest 112 (1997) 296-300S
13. Kleikamp G., Schnepper U., and Korfer R. Coronary artery disease and aortic valve disease as a long-term sequel of mediastinal and thoracic irradiation. J Thorac Cardiovasc Surg 45 (1997) 27-31
14. Shulimzor T., Apter S., Weitzen R., Yellin A., Brenner R.J., and Wollner A. Radiation pneumonitis complicating mediastinal radiotherapy postpneumonectomy. Eur Respir J 9 (1996) 2697-2699
15. Yeoh E., Holloway R.H., Russo A., Tippett M., Bermingham H., Challerton B., and Horowitz M. Effects of mediastinal irradiation on oesophageal function. Gut 38 (1996) 166-170
16. Cionini L., Pacini P., De Paola E., Corrado A., De Luca Cardillo C., Mungay V., Biti G.P., and Ponticelli P. Respiratory function testes after mantle irradiation in patients with Hodgkin disease. Acta Radiol Oncol 23 (1984) 401-409
17. Monden Y., Nakahara K., Iioka S., Najo S., Ohno K., Fujii Y., Hashimoto J., Kitagawa Y., Masaoka A., and Kawashim Y. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39 (1985) 165-169
18. Curran Jr. W.J., Kornstein M.J., Brooks J.J., and Turrisi III A.T. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete resection. J Clin Oncol 6 (1988) 1722-1727
19. Ogawa K., Uno T., Toita T., Onishi H., Yoshida H., Kakinobana Y., Adachi G., Itomi J., Ito H., and Murayama S. Postoperative radiotherapy for patients with completely resected thymoma: a multiinstitutional, retrospective review of 103 patients. Cancer 94 (2002) 1405-1413
20. Ruffini E., Mancuso M., Oliaro A., Casadio C., Cavallo A., Cianci R., Filoso P.L., Molinatti M., Porrello C., Cappello N., and Maggi G. Recurrence of thymoma: analysis of clinicopathologic features, treatment and outcome. J Thorac Cardiovasc Surg 113 (1997) 55-63
21. Quintanilla-Martinez L., Wilkins Jr. E.W., Choi N., Efrid J., Hug E., and Harris N.L. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 74 (1994) 606-617
22. Mangi A.A., Wright C.D., Allan J.S., Wain J.C., Donahue D.M., Grillo H.C., and Mathisen D.J. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74 (2002) 1033-1037
23. Singhal S., Shrager J.B., Rosenthal D.I., LiVolsi V.A., and Kaiser L.R. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1642